Literature DB >> 33020922

TNFRp75-dependent immune regulation of alveolar macrophages and neutrophils during early Mycobacterium tuberculosis and Mycobacterium bovis BCG infection.

Avril Walters1, Roanne Keeton1, Antoinette Labuschagné1, Nai-Jen Hsu1, Muazzam Jacobs1,2,3.   

Abstract

TNF signalling through TNFRp55 and TNFRp75, and receptor shedding is important for immune activation and regulation. TNFRp75 deficiency leads to improved control of Mycobacterium tuberculosis (M. tuberculosis) infection, but the effects of early innate immune events in this process are unclear. We investigated the role of TNFRp75 on cell activation and apoptosis of alveolar macrophages and neutrophils during M. tuberculosis and M. bovis BCG infection. We found increased microbicidal activity against M. tuberculosis occurred independently of IFNy and NO generation, and displayed an inverse correlation with alveolar macrophages (AMs) apoptosis. Both M. tuberculosis and M. bovis BCG induced higher expression of MHC-II in TNFRp75-/- AMs; however, M bovis BCG infection did not alter AM apoptosis in the absence of TNFRp75. Pulmonary concentrations of CCL2, CCL3 and IL-1β were increased in TNFRp75-/- mice during M, bovis BCG infection, but had no effect on neutrophil responses. Thus, TNFRp75-dependent regulation of mycobacterial replication is virulence dependent and occurs independently of early alveolar macrophage apoptosis and neutrophil responses.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Mycobacterium tuberculosiszzm321990; BCG; TNF; TNF receptor; apoptosis; macrophage; neutrophil

Mesh:

Substances:

Year:  2020        PMID: 33020922      PMCID: PMC7808150          DOI: 10.1111/imm.13277

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  72 in total

1.  Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice.

Authors:  J C Leemans; N P Juffermans; S Florquin; N van Rooijen; M J Vervoordeldonk; A Verbon; S J van Deventer; T van der Poll
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

2.  Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis.

Authors:  M I Sadek; E Sada; Z Toossi; S K Schwander; E A Rich
Journal:  Am J Respir Cell Mol Biol       Date:  1998-09       Impact factor: 6.914

3.  Human alveolar macrophage gene responses to Mycobacterium tuberculosis strains H37Ra and H37Rv.

Authors:  Richard F Silver; Jessica Walrath; Hung Lee; Bruce A Jacobson; Heidi Horton; Michael R Bowman; Karl Nocka; Joseph P Sypek
Journal:  Am J Respir Cell Mol Biol       Date:  2008-09-11       Impact factor: 6.914

4.  Mycobacterium tuberculosis prevents inflammasome activation.

Authors:  Sharon S Master; Silvana K Rampini; Alexander S Davis; Christine Keller; Stefan Ehlers; Burkhard Springer; Graham S Timmins; Peter Sander; Vojo Deretic
Journal:  Cell Host Microbe       Date:  2008-04-17       Impact factor: 21.023

5.  Efferocytosis is an innate antibacterial mechanism.

Authors:  Constance J Martin; Matthew G Booty; Tracy R Rosebrock; Cláudio Nunes-Alves; Danielle M Desjardins; Iris Keren; Sarah M Fortune; Heinz G Remold; Samuel M Behar
Journal:  Cell Host Microbe       Date:  2012-09-13       Impact factor: 21.023

6.  IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection.

Authors:  Cecile M Fremond; Dieudonnée Togbe; Emilie Doz; Stephanie Rose; Virginie Vasseur; Isabelle Maillet; Muazzam Jacobs; Bernhard Ryffel; Valerie F J Quesniaux
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

7.  Lung environment determines unique phenotype of alveolar macrophages.

Authors:  Amanda M Guth; William J Janssen; Catharine M Bosio; Erika C Crouch; Peter M Henson; Steven W Dow
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-03-20       Impact factor: 5.464

8.  Differences in reactivation of tuberculosis induced from anti-TNF treatments are based on bioavailability in granulomatous tissue.

Authors:  Simeone Marino; Dhruv Sud; Hillarie Plessner; Philana Ling Lin; John Chan; JoAnne L Flynn; Denise E Kirschner
Journal:  PLoS Comput Biol       Date:  2007-08-22       Impact factor: 4.475

9.  Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity.

Authors:  Kamar-Sulu N Atretkhany; Ilgiz A Mufazalov; Josefine Dunst; Anna Kuchmiy; Violetta S Gogoleva; David Andruszewski; Marina S Drutskaya; Denise L Faustman; Marius Schwabenland; Marco Prinz; Andrey A Kruglov; Ari Waisman; Sergei A Nedospasov
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-29       Impact factor: 11.205

10.  Innate myeloid cell TNFR1 mediates first line defence against primary Mycobacterium tuberculosis infection.

Authors:  Noria Segueni; Sulayman Benmerzoug; Stéphanie Rose; Amandine Gauthier; Marie-Laure Bourigault; Flora Reverchon; Amandine Philippeau; François Erard; Marc Le Bert; Hélène Bouscayrol; Thierry Wachter; Irène Garcia; George Kollias; Muazzam Jacobs; Bernhard Ryffel; Valerie F J Quesniaux
Journal:  Sci Rep       Date:  2016-03-02       Impact factor: 4.379

View more
  1 in total

Review 1.  Transmembrane TNF and Its Receptors TNFR1 and TNFR2 in Mycobacterial Infections.

Authors:  Andy Ruiz; Yadira Palacios; Irene Garcia; Leslie Chavez-Galan
Journal:  Int J Mol Sci       Date:  2021-05-22       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.